Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography
RecruitingNCT07638137
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
AID Post-PCI Angina is as an observational, prospective, single-cohort, multicenter study designed to investigate the causes and origins of post-PCI angina by using the advance invasive diagnosis (AID) strategy combining with angiography derived physiology (ADP) in an all-comers population of patients with post-PCI angina referred for invasive coronary angiography. An all-comers population of patients with a history of previous percutaneous coronary intervention (PCI), who presented with angina or documented myocardial ischemia by non-invasive testing and are referred for invasive coronary angiography (ICA) will be enrolled. ICA will be performed with the application of the structure AID strategy to evaluate both obstructive and non-obstructive cause of myocardial ischemia. Then, angiography derived physiological assessment of epicardial coronary artery using functional coronary angiography in each vessel will be performed in both index procedure and the previous procedure in all patients. By combining information obtained from both procedures, the causes and origins of post-PCI angina will be made. Treatment will be decided by the operators according to the result. Patients will complete the Seattle Angina Questionnaire (SAQ) at baseline and at 1, 6, and 12 months after the procedure. The main hypothesis of this study states that, in patients with post-PCI angina referred to ICA, the application of the structured AID strategy combining with angiography derived physiology (ADP) will lead to a high diagnostic yield in identifying the origins of obstructive disease and causes of post-PCI angina.
Study details
- Official title
- Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography: the AID Post-PCI Angina Study
- Conditions
- Angina (Stable)
- Percutaneous Coronary Intervention (PCI)
- INOCA (Ischemia With Non Obstructive Coronary Artery Disease)
- Chronic Coronary Syndrome
- Interventions
- Diagnostic test: An advanced invasive diagnosis (AID) strategy combining with angiography derived physiology (ADP)
- Sponsor
- Fundacion Investigacion Interhospitalaria Cardiovascular
- Collaborators
- Instituto de Salud Carlos III
- Start date
- 2025-03-12
- Primary completion
- 2027-03-30
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Spain
- Total sites listed
- 5
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with a history of previous percutaneous coronary intervention (PCI) with drug eluting stent (DES), bare metallic stent (BMS), or drug coated balloon (DCB) due to acute coronary syndrome or chronic coronary syndrome, who presented with angina or documented myocardial ischemia by non-invasive testing and are referred for invasive coronary angiography. Exclusion Criteria: * Acute myocardial infarction (ST-segment elevation myocardial infarction \[STEMI\] and non-ST-segment elevation myocardial infarction \[NSTEMI\]). * Age \< 18 years old. * Pregnancy. * Severe left ventricle systolic dysfunction (left ventricular ejection fraction ≤30 %). * Congestive heart failure with reduced ejection fraction. * Concomitant severe valvular heart disease. * Severely decreased renal function (glomerular filtration rate \< 30 mL/min/1.73 m2). * Significant epicardial coronary artery disease unable to be treated by PCI. * Previous coronary artery bypass grafting (CABG). * Presence of any anatomic features precluding intracoronary instrumentation with pressure guidewires. * Contraindications to the administration of adenosine or acetylcholine.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07638137